June 3 (Reuters) - Illumina ( ILMN ), a maker of gene
sequencing machines, said on Monday it expected to spin off
cancer test maker Grail.
On June 24, shareholders of Illumina ( ILMN ) will receive one share
of Grail common stock for every six shares of Illumina ( ILMN ) common
stock held at the close of business on June 13, 2024.
Illumina ( ILMN ) said it would retain a 14.5% stake in Grail.